在欧洲患有急性淋巴细胞白血病的儿科患者中与常用药物的抗真菌药物相互作用
Beata Sienkiewicz-Oleszkiewicz1, Małgorzata Salamonowicz-Bodzioch2, Justyna Słonka3
1Department of Clinical Pharmacology, Faculty of Pharmacy, Wrocław Medical University, ul. Borowska 211a, 50-556 Wrocław, Poland.
Journal of clinical medicine
|July 29, 2023
概括
本综述检查了抗真菌药物和常见的儿科白血病治疗之间的药物相互作用. 埃奇诺坎丁和脂质体安福特里辛B具有良好的安全性,但建议使用多重相互作用检查器.
科学领域:
- 儿科血液瘤学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 急性淋巴细胞白血病 (ALL) 是一种常见的儿童癌症.
- 侵袭性真菌感染在儿科血液瘤病房中构成重大风险.
- 使用抗真菌药物需要仔细考虑药物相互作用 (DDI).
研究的目的:
- 对抗真菌剂和儿科血液瘤学常见药物之间的潜在DDI进行审查.
- 专注于脂质体安二B及其在急性淋巴细胞白血病治疗中的相互作用.
- 评估这种脆弱人群中抗真菌药物的安全性.
主要方法:
- 从Micromedex®和Drugs.com®相互作用数据库收集的信息.
- EudraVigilance®数据库用于识别来自DDI的严重不良药物反应.
- 对特定于儿科血液瘤学设置的潜在DDI的审查.
主要成果:
- 确定了几个重要的DDI.
- 埃奇诺坎丁和脂质体安福特里辛B的安全性表现良好.
- 药物相互作用检查工具可能提供不同的结果,需要使用多个资源.
结论:
- 脂质组的安福特里辛B和埃奇诺坎丁似乎可以安全地用于儿科ALL患者.
- 仔细的DDI监测在儿科血液瘤学中至关重要.
- 使用多个药物相互作用数据库可以提高DDI识别的准确性.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Antiasthma Drugs: Leukotriene Modifiers
361
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
361
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
164
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
164
Factors Affecting Protein-Drug Binding: Drug Interactions
200
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
200


